A type III-A CRISPR–Cas system mediates co-transcriptional DNA cleavage at the transcriptional bubbles in close proximity to active effectors
Open Access
- 1 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (13) , 7628-7643
Abstract
Many type III CRISPR–Cas systems rely on the cyclic oligoadenylate (cOA) signaling pathway to exert immunization. However, LdCsm, a type III-A lactobacilli immune system mediates efficient plasmid clearance in spite of lacking cOA signaling. Thus, the system provides a good model for detailed characterization of the RNA-activated DNase in vitro and in vivo. We found ATP functions as a ligand to enhance the LdCsm ssDNase, and the ATP enhancement is essential for in vivo plasmid clearance. In vitro assays demonstrated LdCsm cleaved transcriptional bubbles at any positions in non-template strand, suggesting that DNA cleavage may occur for transcribing DNA. Destiny of target plasmid versus nontarget plasmid in Escherichia coli cells was investigated, and this revealed that the LdCsm effectors mediated co-transcriptional DNA cleavage to both target and nontarget plasmids, suggesting LdCsm effectors can mediate DNA cleavage to any transcriptional bubbles in close proximity upon activation. Subcellular locations of active LdCsm effectors were then manipulated by differential expression of LdCsm and CTR, and the data supported the hypothesis. Strikingly, stepwise induction experiments indicated allowing diffusion of LdCsm effector led to massive chromosomal DNA degradation, suggesting this unique IIIA system can facilitate infection abortion to eliminate virus-infected cells.Keywords
Funding Information
- Chinese National Transgenic Science and Technology Program (2019ZX08010003)
- National Natural Science Foundation of China (31771380, 31670061, 31970546, 31970119)
- Danish Council for Independent Research (DFF-4181-00274)
This publication has 62 references indexed in Scilit:
- Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas SystemJournal of Bacteriology, 2013
- Crystal Structure of the Cmr2–Cmr3 Subcomplex in the CRISPR–Cas RNA Silencing Effector ComplexJournal of Molecular Biology, 2013
- Structure and Activity of the RNA-Targeting Type III-B CRISPR-Cas Complex of Thermus thermophilusMolecular Cell, 2013
- A novel interference mechanism by a type IIIB CRISPR‐Cmr module in SulfolobusMolecular Microbiology, 2013
- Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing siteProceedings of the National Academy of Sciences, 2011
- CRISPR/Cas, the Immune System of Bacteria and ArchaeaScience, 2010
- RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein ComplexCell, 2009
- CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNAScience, 2008
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007
- Southern blottingNature Protocols, 2006